CA
ATEX icon

Crewe Advisors’s Anterix ATEX Stock Holding History

Crewe Advisors’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,000
Closed -$115K – 1140
2026
Q1 		$115K Buy
+3,000
New +$94.9K 0.01% 274

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PM
Plustick Management Charlottesville, Virginia $269M AUM 340.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Crewe Advisors's ATEX Position: Q2 2026 in Review

Crewe Advisors sold out of Anterix (ATEX) in Q2 2026, closing a stake of 3,000 shares — an estimated $115K sold.

Crewe Advisors first reported a position in ATEX in Q1 2026 and held it in 1 quarter. The position peaked at $115K in Q1 2026. 171 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Crewe Advisors reported no remaining Anterix position as of Q2 2026 after selling out during the quarter.
  • Crewe Advisors sold 3,000 Anterix shares in Q2 2026, an estimated $115K.
  • Crewe Advisors first reported a position in Anterix in Q1 2026 and held it in 1 quarter.
  • Crewe Advisors's Anterix position peaked at $115K in Q1 2026.
  • 171 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.